[Real-world data come from patients not in clinical trials
A personal or family history of certain thyroid or pancreatic issues may require further evaluation to determine candidacy
Even the lower dosage groups, such as 4 mg, demonstrated measurable improvements in fasting glucose, insulin resistance, and HbA1c
For weight management, NICE (TA875) recommends semaglutide 2.4 mg (Wegovy) for adults with a BMI of 35 kg/m or greater (or 32.5 kg/m or greater for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) who have at least one weight-related comorbidity
The result: GLP-1 drugs trick our hunger meters so people now feel full longer on less food
Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus